Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nursing home drug safety study aims to cut risky prescribing

NCT ID NCT07407387

Knowledge-focused Sponsor: Lugano Istituti Sociali Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 26, 2026 · Updated 2 times

Summary

This study tests whether a team of clinical pharmacologists can help reduce unsafe medication use in nursing homes. Researchers will review each resident's medications, give feedback to staff, and provide education. The study involves 219 residents aged 65+ in seven Swiss nursing homes, comparing outcomes before and after the intervention.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that a structured medication review by clinical pharmacologists reduces unsafe prescribing and improves health outcomes for elderly nursing home residents.
What could go wrong
This is a small, non-randomized study with no control group, so results may not be generalizable. The intervention is complex and may be difficult to implement in other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 219 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Expected to remain in the nursing home for the duration of the study * Able to provide informed consent or having a legally authorized representative able to provide consent if the resident lacks capacity Exclusion Criteria: * Residents in their probable last hours or days of life * Residents with moderate to severe cognitive impairment (Cognitive Performance Scale, CPS, score \>4 * Residents housed in assisted nursing home wards, including those requiring palliative care (either in dedicated palliative units or receiving palliative care in general wards), those in the hemodialysis unit, and those with severe obesity (body mass index \>=40kg/m2)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inappropriate prescribing are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inappropriate prescribing

Contacts and locations

Locations

  • Institute of Pharmacological Science of Southern Switzerland, Ente Ospedaliero Cantonale

    Lugano, 6900, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.